The Discounted Cash Flow (DCF) valuation of Orchid Pharma Ltd (ORCHPHARMA.NS) is 300.05 INR. With the latest stock price at 716.00 INR, the upside of Orchid Pharma Ltd based on DCF is -58.1%.
Based on the latest price of 716.00 INR and our DCF valuation, Orchid Pharma Ltd (ORCHPHARMA.NS) is a sell. selling ORCHPHARMA.NS stocks now will result in a potential gain of 58.1%.
| Range | Selected | |
| WACC / Discount Rate | 10.8% - 13.1% | 12.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 230.56 - 419.75 | 300.05 |
| Upside | -67.8% - -41.4% | -58.1% |